Article
Plattel, Wouter J., Teesink, Sophie
ORCID: 0009-0009-6912-1533, Visser, Lydia, Voltin, Conrad‐Amadeus
ORCID: 0000-0002-5437-3959, Kaul, Helen, Schlößer, Hans A.
ORCID: 0000-0002-1304-7719, Kroesen, Bart‐Jan, Kobe, Carsten
ORCID: 0000-0002-2909-0826, von Tresckow, Bastian, Borchmann, Peter, Diepstra, Arjan and Bröckelmann, Paul J.
ORCID: 0000-0001-9662-9900
(2025).
Serum TARC dynamics during anti‐PD1‐based first‐line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial.
HemaSphere, 9 (8).
pp. 1-5.
Wiley.
ISSN 2572-9241
Rosenbrock, Johannes
ORCID: 0000-0003-3340-0556, Kaul, Helen, Oertel, Michael, Celik, Eren, Linde, Philipp
ORCID: 0000-0002-2813-1331, Fan, Jiaqi, Eichenauer, Dennis A.
ORCID: 0000-0002-1927-3514, Bröckelmann, Paul J.
ORCID: 0000-0001-9662-9900, von Tresckow, Bastian
ORCID: 0000-0003-1410-4487, Kobe, Carsten
ORCID: 0000-0002-2909-0826, Dietlein, Markus
ORCID: 0000-0003-0992-6099, Fuchs, Michael
ORCID: 0000-0003-3289-3272, Borchmann, Peter
ORCID: 0000-0003-3782-2158, Eich, Hans Theodor and Baues, Christian
(2024).
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group.
International journal of radiation oncology, biology, physics, 120 (5).
pp. 1344-1352.
Elsevier Science.
ISSN 0360-3016
Up a level